Review
Open access
Sep 2026
Current, novel and emerging lipid-lowering therapies in pediatric familial hypercholesterolemia.
As therapeutic options expand and agents with greater LDL-C reductions become available, personalized treatment strategies will become increasingly important to achieve LDL-C targets and may ultimately shift from stepwise intensification approaches toward early intensive treatment.
Eelke Houter, S. E. van den Bosch, B. Hutten et al.
· Current Opinion in Lipidolog... · 0 citations